Skip to Main Content

Paper Details

Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials.
ACS Chem Neurosci
14
2018
AKT, DNA, EGFR, ERK, GBM, NF1, PI3K, PTEN, RAF, RAS, bosutinib, cabozantinib, cancers, glioblastoma, heterogeneous tumor cells, ibrutinib, mRNA-seq transcriptome, mTOR, pan-cancer, patient, patients, receptor tyrosine kinases, tumor, tumor genomics, tyrosine
Author NameAffiliation
Mehdi BouhaddouDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Marc R BirtwistleDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Marc R BirtwistleClemson University
Marc R BirtwistleDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Marc R BirtwistleClemson University
  • 1 - 5

Datasets

Release 1.2